Scottish Court Approves Group Lawsuit Against Johnson & Johnson Over Talc

The Court of Session in Scotland has approved a group legal action against pharmaceutical giant Johnson & Johnson over claims that its talcum powder caused cancer.

Around 300 Scottish claimants diagnosed with cancer after using the company’s baby powder have been granted permission to proceed with the lawsuit.

The suit alleges that Johnson & Johnson knowingly sold talcum powder contaminated with asbestos, leading to serious illnesses including ovarian cancer, mesothelioma, fallopian tube cancer, and peritoneal cancer. Johnson & Johnson denies the allegations.

In granting permission, the court ruled that the claims have a real prospect of success and that group proceedings are the appropriate mechanism to address them.

The case is believed to be the first group action of its kind against Johnson & Johnson in Scotland.

More than 7,000 claimants across the UK have brought similar claims in what has been described as potentially the largest product liability group action in UK legal history. Johnson & Johnson withdrew its talc-based baby powder from the UK market in 2023.

The company has previously maintained that its talc products complied with all regulatory standards, did not contain asbestos, and do not cause cancer.

Dominic Ritchie, partner and head of group actions at the law firm Jones Whyte, said: "This is an important step for people in Scotland who believe they were harmed by these products. Anyone in Scotland who used Johnson & Johnson talcum powder and has since been diagnosed with cancer should feel able to come forward."

Why it matters

The ongoing legal battles surrounding talc highlight the critical importance of ingredient safety and regulatory compliance for the global personal care sector. As legacy giants grapple with massive product liability claims, the broader cosmetics industry is shifting toward alternative formulations and clean beauty. This evolving landscape has paved the way for agile indie brands to capture market share, such as Nopalera raising $4 million to expand its clean, culture-forward personal care lineup in major retail spaces.